> Details

Appel, Katharina S.; Lee, Chin Huang; Nunes de Miranda, Susana M.; Maier, Daniel; Reese, Jens-Peter; Anton, Gabriele; Bahmer, Thomas; Ballhausen, Sabrina; Balzuweit, Beate; Bellinghausen, Carla; Blumentritt, Arne; Brechtel, Markus; Chaplinskaya-Sobol, Irina; Erber, Johanna; Fiedler, Karin; Geisler, Ramsia; Heyder, Ralf; Illig, Thomas; Kohls, Mirjam; Kollek, Jenny; Krist, Lilian; Lorbeer, Roberto; Miljukov, Olga; Mitrov, Lazar; [...]

A precise performance-based reimbursement model for the multi-centre NAPKON cohorts – development and evaluation

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: A precise performance-based reimbursement model for the multi-centre NAPKON cohorts – development and evaluation
  • Contributor: Appel, Katharina S.; Lee, Chin Huang; Nunes de Miranda, Susana M.; Maier, Daniel; Reese, Jens-Peter; Anton, Gabriele; Bahmer, Thomas; Ballhausen, Sabrina; Balzuweit, Beate; Bellinghausen, Carla; Blumentritt, Arne; Brechtel, Markus; Chaplinskaya-Sobol, Irina; Erber, Johanna; Fiedler, Karin; Geisler, Ramsia; Heyder, Ralf; Illig, Thomas; Kohls, Mirjam; Kollek, Jenny; Krist, Lilian; Lorbeer, Roberto; Miljukov, Olga; Mitrov, Lazar; [...]
  • Published: Springer Science and Business Media LLC, 2024
  • Published in: Scientific Reports, 14 (2024) 1
  • Language: English
  • DOI: 10.1038/s41598-024-63945-5
  • ISSN: 2045-2322
  • Origination:
  • Footnote:
  • Description: AbstractFair allocation of funding in multi-centre clinical studies is challenging. Models commonly used in Germany - the case fees (“fixed-rate model”, FRM) and up-front staffing and consumables (“up-front allocation model”, UFAM) lack transparency and fail to suitably accommodate variations in centre performance. We developed a performance-based reimbursement model (PBRM) with automated calculation of conducted activities and applied it to the cohorts of the National Pandemic Cohort Network (NAPKON) within the Network of University Medicine (NUM). The study protocol activities, which were derived from data management systems, underwent validation through standardized quality checks by multiple stakeholders. The PBRM output (first funding period) was compared among centres and cohorts, and the cost-efficiency of the models was evaluated. Cases per centre varied from one to 164. The mean case reimbursement differed among the cohorts (1173.21€ [95% CI 645.68–1700.73] to 3863.43€ [95% CI 1468.89–6257.96]) and centres and mostly fell short of the expected amount. Model comparisons revealed higher cost-efficiency of the PBRM compared to FRM and UFAM, especially for low recruitment outliers. In conclusion, we have developed a reimbursement model that is transparent, accurate, and flexible. In multi-centre collaborations where heterogeneity between centres is expected, a PBRM could be used as a model to address performance discrepancies.Trial registration: https://clinicaltrials.gov/ct2/show/NCT04768998; https://clinicaltrials.gov/ct2/show/NCT04747366; https://clinicaltrials.gov/ct2/show/NCT04679584.
  • Access State: Open Access